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Complement dysregulation is a feature of many
retinal diseases, yet mechanistic understanding at
the cellular level is limited. Given this knowledge
gap about which retinal cells express complement,
we performed single-cell RNA sequencing on
92,000 mouse retinal cells and validated our results
in five major purified retinal cell types. We found ev-
idence for a distributed cell-type-specific comple-
ment expression across 11 cell types. Notably,
M€uller cells are the major contributor of complement
activators c1s, c3, c4, and cfb. Retinal pigment
epithelium (RPE) mainly expresses cfh and the termi-
nal complement components, whereas cfi and cfp
transcripts are most abundant in neurons. Aging en-
hances c1s, cfb, cfp, and cfi expression, while cfh
expression decreases. Transient retinal ischemia in-
creases complement expression in microglia, M€uller
cells, and RPE. In summary, we report a unique com-
plement expression signature for murine retinal cell
types suggesting a well-orchestrated regulation of
local complement expression in the retinal microen-
vironment.
INTRODUCTION
Single-nucleotide polymorphisms in complement genes are
associated with a number of retinal diseases, including glau-
coma (Scheetz et al., 2013), age-related macular degeneration
(AMD) (Weber et al., 2014), and diabetic retinopathy (YangCell Repor
This is an open access article under the CC BY-Net al., 2016; Wang et al., 2013). The immune-privileged retina is
among others under regular immune surveillance by proteins of
the complement system. Although systemic complement is
known to perform homeostatic functions that include opsoniza-
tion for phagocytosis, formation of membrane attack complexes
(MACs), and recruitment of immune cells (Merle et al., 2015), the
local regulation of complement within the cellular architecture of
the neurosensory retina is poorly understood. Current evidence
suggests that complement components are locally expressed
in the retinal pigment epithelium (RPE) (Scha¨fer et al., 2017;
Luo et al., 2011; Anderson et al., 2010; Tian et al., 2015; Li
et al., 2014; Rutar et al., 2012) as well as microglia (Rutar et al.,
2012) and could be independent of the systemic complement,
which is produced in hepatocytes and distributed via the blood-
stream. A retinal complement system may help facilitate a rapid
response to microbial invasion and disposal of damaged cells
despite an intact blood-retina barrier.
Upregulation of complement expression, subsequent protein
deposition, and MAC formation have been demonstrated in the
normal aging (Chen et al., 2010; Ma et al., 2013; Chen et al.,
2008) and diseased retina (Crabb, 2014; Sudharsan et al.,
2017; Radu et al., 2011; Zhang et al., 2002; Kuehn et al., 2008).
In fact, complement components present in extracellular de-
posits (termed ‘‘drusen’’) are the hallmark of AMD (Crabb,
2014). Consequently, it is tempting to speculate that a source
of complement components during aging could be the retina/
RPE itself, as animal studies have shown increased retinal
expression of c1q, c3, c4, and cfb in older mice (Ma et al.,
2013; Chen et al., 2010). Complement upregulation has also
been observed in retinitis pigmentosa (Sudharsan et al., 2017),
Stargardt disease (Radu et al., 2011), and conditions associated
with transient ischemic tissue damage, viz. diabetic retinopathy
(Zhang et al., 2002) and glaucoma (Andreeva et al., 2014; Kuehnts 29, 2835–2848, November 26, 2019 ª 2019 The Author(s). 2835
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
et al., 2008; Kim et al., 2013). Despite a clear indication for a
fundamental role of the complement system in the retina, it re-
mains unknown which retinal cell populations shape comple-
ment homeostasis in the healthy, aging, and diseased retina.
The retina consists of more than 40 different cell types, which
cooperate to capture, process, and transmit visual signals to the
brain (Macosko et al., 2015; Tian et al., 2015; Rheaume et al.,
2018; Shekhar et al., 2016). Our understanding of the healthy
and diseased retina and its supporting tissues like the RPE and
choriocapillaris has grown recently (Tian et al., 2015; Pinelli
et al., 2016). Transcriptomic studies have focused on the whole
retina or RPE but miss information about cell-type-specific tran-
scription (Pinelli et al., 2016; Tian et al., 2015). Droplet-based sin-
gle-cell RNA sequencing (scRNA-seq) has identified the molec-
ular differences among retinal ganglion cells (Rheaume et al.,
2018), bipolar cells (Shekhar et al., 2016), and M€uller cells
(Roesch et al., 2008), but these studies provided little insight
into complement expression of the major retinal cell types and
changes occurring with aging and degeneration.
Here, we profile complement expression at the single-cell level
in themajor 11 retinal cell types of themouse and further validate
these results in enriched M€uller cells, vascular cells, microglia,
neurons, and RPE cells. We observed a characteristic contribu-
tion of complement transcripts from distinct retinal cell popula-
tions. Our data suggest that the classical and alternative
complement pathway could be activated solely by local comple-
ment production and thereby could induce C3 cleavage. CFH
is the major complement inhibitor in the mouse retina; retinal
stress consistently downregulates cfh expression. Moreover,
cell-type-specific changes in complement expression differed
in aging and acute retinal degeneration induced by transient
ischemia, implying a stress-dependent and cell-type-specific
modulation of retinal complement homeostasis mediated by
the tissue itself.
RESULTS
Single-Cell RNA Sequencing Reveals Complement
Component Expression across Multiple Cell Types
Retinal cells, 92,000 total, were isolated from six male healthy
C57BL/6J mice and separated for scRNA-seq (Macosko et al.,
2015; Shekhar et al., 2016; Cheng et al., 2013b; Kim et al.,
2008). Following sequencing, the data were analyzed using 30
principal components as input to the t-Distributed Stochastic
Neighbor Embedding (t-SNE) method for dimension reduction
and data visualization (Figures 1A and S1). Cells were classified
into elevenmajor types based on establishedmarkers (Tables S1
and S2). We then mapped the expression of complement genes
across all 11 cell types and observed a distributed expression of
complement components across various resident cells in the
retina (Figure 1B; Table S3).We detected cell-type-specific com-
plement expression mainly in the classical pathway via scRNA-
seq. Moreover, we mapped the cell-type-dependent expression
of both soluble and membrane-bound complement regulators
(Figure 1C; Table S3) and found main soluble regulators cfh,
vtn, and clu. Cell types expressing complement regulators at
the highest levels were M€uller cells, pericytes, and endothelial
cells. Complement receptors, which detect complement activa-2836 Cell Reports 29, 2835–2848, November 26, 2019tion (anaphylatoxins or opsonins), were only expressed in micro-
glia cells (Figure 1B; Table S3).
The results from scRNA-seq regarding complement compo-
nent transcription were exemplary validated using RNA fluores-
cence in situ hybridization (FISH) (Figure 2). Complement
component c4 expression colocalized with gfap-positive astro-
cytes/M€uller cells in the retinal ganglion cell layer (GCL) (Fig-
ure 2A), which correlated with scRNA-seq data (Figure 1B).
The scRNA-seq data were also confirmed for complement regu-
lator cfi, which was specifically detected in bipolar cells both by
transcription analyses (Figure 1C) and via RNA-FISH (Figure 2B).
Complement receptor c1qbpwas detected in all cell populations
in RNA sequencing (RNA-seq) (Figure 1B). In line with that, we
found a colocalization of c1qpb transcripts with markers of
microglia/macrophages (hereafter termed microglia) (tmem119)
in the GCL (Figure 2C), but rather evenly distributed signals
were detected in all retinal layers except for the inner nuclear
layer (INL).
qPCR-Based mRNA Analyses of Purified Neurons,
M€uller Cells, Microglia, Vascular Cells, and RPE
Decipher the Differentially Transcriptional Relevance of
Retinal Cells
Though our single-cell analysis uncovered complement expres-
sion in different cell types, some complement components re-
mained undetectable or were found in relatively rare cell types
at the single-cell level (Table S3). Therefore, we further validated
our results on M€uller cells, microglia, vascular cells, and retinal
neurons purified by immunomagnetic cell separation using
quantitative real-time PCR. RPE was purified through manual
scratching of eyecups from male and female albino BALB/c
and pigmented C57BL/6 mice (Figure 3A) (Grosche et al.,
2016). All five cell populations were characterized by the expres-
sion of specific marker genes (Figures 3A–3F).
Commonly used housekeeping genes showed high transcrip-
tional and translational variability across different cell types (Fig-
ures S2A–S2D) except pyruvate dehydrogenase E1 component
subunit beta (pdhb) (Figures S2E and S2F) and isocitrate dehy-
drogenase 3 (NAD+) beta (idh3b) (Figures S2G and S2H), which
had relatively homogeneous expression levels. We decided to
use idh3b to determine how distinct cell populations proportion-
ally contributed to the total retinal complement transcriptome,
because it showed expression levels similar to those of the com-
plement genes, while gapdh, for example, was expressed at
much higher levels and thus appeared to be less appropriate
(Figure S2C). Based on idh3b, we estimate that the neuronal
fraction contributes 60% of the total retina transcriptome and
M€uller cells contribute 25% (Figure 4A). Vascular cells and mi-
croglia expressed lower levels of idh3b, indicating low cell
numbers and/or low transcription activity of these cell types in
the mouse retina. Quantifying total RNA by RNA picochip
analysis, we found similar RNA quantities in M€uller cells (33%),
neurons (26%), and the RPE/choroid fraction (22%) per mouse
(Figure 4B). In accordance with these results, PDHB protein
levels were relatively similar across M€uller cells, neurons, and
RPE cells (Figure 4C), whereas microglia and vascular cells
showed weaker PDHB signals. In agreement with previous re-
ports of cell counts in the mouse, we found neurons make
Figure 1. Single-Cell RNA-Seq of Murine Retina Reveals Complement Expression in Different Cell Types
Distribution of complement expression in normal mouse retina is delineated by single-cell transcriptomics.
(A) Using unsupervised clustering, we detect all 11 major cell classes in the mouse retina; the distinct cell types that passed quality control (described in STAR
Methods) are shown in a t-SNEmap (out of the 92,343 cells total, 91,798 cells passed the filter of having mitochondrial gene expression <50%, and 200 < unique
gene counts <3,500). Percentages of assigned cell types are summarized in the right panel. BC, bipolar cell.
(B) Cell-type-specific expression of complement genes is shown in a heatmap. Mean expression values of the genes were calculated in each cluster by randomly
subsampling a population of 100 cells for each cell type. Each row represents a retinal cell type, and each column corresponds to a gene.
(C) The expression of complement regulators among the various retinal cell types is shown bymeans of a dot plot. Cell types are arranged roughly by their location
in the retina, from the inner layer (top) to the outer layer (bottom). The size of each circle (pct.exp) depicts the percentage of cells in which the gene was detected
for a given cell type, and its color depicts the average transcript count in the expressing cells (avg.exp.scale).
See also Figure S1 and Tables S1–S3.up 85%, RPE cells 13%, M€uller cells 2%, and microglia and
vascular cells are less than 1% of all retinal cell types (Figure 4D;
Table S2) (Jeon et al., 1998). While M€uller cells are a compara-tively infrequent cell type (2%), they contribute up to one third
of the total mRNA content in the retina (Figures 1A, 4A, 4B,
and 4D; Table S2). Accordingly, our study provides importantCell Reports 29, 2835–2848, November 26, 2019 2837
(legend on next page)
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Figure 3. Validation of Enrichment of
Different Retinal Cell Types
(A) Schematic view of distinct retinal cell types.
M€uller cells (blue), the central glia cells of the retina,
are in direct contact with the vitreous and various
retinal cell types: microglia (green), vascular cells
(red), and neurons (gray). 80% of the retinal neu-
rons are light-responsive photoreceptors that are
supported by retinal pigment epithelial cells (RPE,
brown).
(B) scRNA-seq data illustrating expression of
glutamine synthetase (glul) across retinal cells (top
panels). Murine retinal cell populations were en-
riched by immunomagnetic cell separation and
characterized by quantitative real-time PCR using
specific markers (bottom panels); Glul is a marker
for the M€uller cell fraction.
(C) Microglia (and putatively co-enriched macro-
phages) specifically express cd11b (itgam).
(D) Vascular cell enrichment was proven by strong
expression of pecam.
(E) Retinal neurons were characterized by an
enhanced detection of the photoreceptor-specific
nrl mRNA compared to the other cell populations.
(F) Rpe65 was exclusively expressed in RPE/
choroid. Exemplarily shown mean values ± SEM
for cell preparations from BALB/c mice at 8, 16,
and 24 weeks of age (n = 4‒6 for each age).
See also Figure S2 and Table S7.insight into the proportional transcriptional activities of these five
major cell populations in the retina.
Retinal Cell Populations Express Unique Complement
Signatures
Encouraged by the distributed complement expression pattern
across 11 cell types (Figures 1B and 1C; Table S3), we hypothe-
sized that specific retinal cell types shape the intraretinal com-Figure 2. Localization of Selected Complement Component Transcripts in the Healthy Retin
rescence In Situ Hybridization
(A) Spots indicative of c4 transcripts were detected in the GCL and clearly overlap with the very few particles p
No transcripts of c4 or, as expected, the astrocyte marker gfap were detected in the INL or outer nuclear la
(B) Cfi expression was very weak in the GCL, with no clear association with cell somata, but was detected at
overlapped with those of the bipolar marker gsg1 (asterisks). In the ONL, probes detecting cfi transcripts pr
background level. A clear distinction regarding whether cfi transcripts are localized in photoreceptors and/or
in the ONL cannot be made.
(C) clqbp transcript was rather evenly distributed across the whole retina. A partial overlap with the microg
(arrowheads). Note that c1qbp transcripts were detected in the inner plexiform layer (IPL), but not in the INL
(D) cfh transcripts were detected at low levels in the GCL and INL, and no clear overlap of signals with that o
seemed to bemore enriched in the outer plexiform layer (OPL). Similarly, cfh transcript levels are low in theON
M€uller glia enwrapping photoreceptor somata.
(E and F) As positive control, probes conjugated either with (E) Quasar 670 (green) or (F) Quasar 570 (red) targe
detection of the transcript especially in association with cell bodies, which confirms the high expression
fluorescence background was detected in the recording channels if no appropriate probe was incubated with
background was detected in the OPL and ONL if no appropriate probe was incubated with the tissue.
Scale bars, 5 mm.
Cell Reportplement homeostasis through expression
of specific complement components. We
selected six disease-associated genes
(Scha¨fer et al., 2017; Weber et al., 2014)(c1s, c3, cfb, cfp, cfh, and cfi) and six supporting complement
genes (c4, cfd, c5, c6, c7, c8, and c9) for further validation via
quantitative real-time PCR and western blot (Figures 4E and
4F) and found that M€uller cells contributed themost complement
activator transcripts, expressing 47% of c1s, 67% of c4, and
54% of c3 retinal transcripts in 8-week-old mice (Figure 4E).
Retinal neurons dominated the expression of the complement
regulators cfi and cfp, while 59% of the cfh, 45% of the cfb,a ofPigmented 10-Week-Old Mice via Fluo-
ositive for the astrocyte marker gfap (arrowheads).
yer (ONL).
a rather high level in the INL. There, signals partially
oduced signals clearly above the autofluorescence
in M€uller glia that ensheathe photoreceptor somata
lia marker tmem119 in the GCL could be validated
.
f the ganglion cell marker pou4f1 was observed. It
L. The staining pattern could reflect an expression in
ting transcripts of gapdhwere used. Note the robust
levels of gapdh detected via scRNA-seq. Auto-
the tissue in the GCL, while some autofluorescence
s 29, 2835–2848, November 26, 2019 2839
Figure 4. Contribution of Retinal Cell Types to the Retinal Architecture, Expressome, and Complement Homeostasis
(A) mRNA expression of the housekeeping gene idh3b as determined in samples from retinal cell populations enriched from retinae of 8-, 16, and 24-week-old
albino mice without adjusting the RNA input amount per cell type. This enables an estimate of the contribution of each cell type to the retinal transcriptome. Bars
represent mean values ± SEM (n = 4‒6).
(B) The total RNA amount isolated from retinal cell populations enriched from albino mice (8 to 16 weeks old) was investigated using picochip analysis. Bars
represent mean values ± SEM (n = 5‒8).
(C) Quantification of PDHB protein expression via western blots performed on five retinal cell types purified from 4‒6 albino mice.
(D) Previously published (Jeon et al., 1998) and our own retinal cell counts in the healthy mouse retina.
(E) Expression levels of indicated complement components were determined from cells of albino mice at mRNA (bars, 8-week-old mice) and at protein level
(western blot, 8- to 24-week -old mice). The overall contribution of each cell population to the local complement homeostasis was determined by analyzing the
total yield of mRNA or protein derived from the respective cell population so that both are reflected by the data (expression level per cell type and the number of
cells per cell type present in the retina).
(F) Scheme of the complement system that can be activated via three different mechanisms and is enhanced by an amplification loop. Note that complement
components only detected at the transcript level are delineated in pink, and those that were also confirmed at the protein level are shown in dark pink. Com-
plement components with higher expression in retinal cell types compared to the RPE/choroid fraction are pinpointed by a thick outline. CP, classical pathway;
AP, alternative pathway.
See also Figures S2 and S3 and Table S7.
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Figure 5. Retinal Phenotype and Complement Homeostasis in Aging
Albino Mice
(A) Expression levels of c1s, c3, cfb, cfp, cfh, and cfi were determined from
cells of albino mice at the mRNA level (bars) at the indicated ages. The overall
putative contribution of each cell population to the local complement ho-
meostasis was determined by analyzing the total yield of mRNA derived from
the respective cell population.
(B–D) The quantities of DAPI+ cell nuclei in the (B) GCL, (C) INL, and (D) ONL
were comparable in 16- to 32-week-old albino retinae.
(E) Left: microglia were quantified in the inner retinal layers (INR) such as
ganglion cell and inner plexiform layer and additionally in the outer plexiform
layer (OPL) on basis of Iba1 labeling in mice of the indicated age. Right: the
area occupied by processes of a single microglia was measured as exem-
plarily depicted by the dashed circles of different color for OPLmicroglia in (D).
Bars represent mean values ± SEM from 2‒4 animals. *p < 0.05, **p < 0.01,
Mann-Whitney U test. See also Figure S2 and Table S7.and 82% of the cfdmRNA and c5‒c9 transcripts responsible for
the terminal MAC were detected in RPE. Despite the relatively
low number of microglia, the resident immune cells of the retinacontributed proportionally more cfhmRNA and a similar amount
of cfb transcripts to the retinal complement population
compared with retinal neurons.
We confirmed expression of complement activator C1s, CFB,
and CFP proteins in all enriched murine cell populations (Fig-
ure 4E). Complement C3 protein was detected in RPE, M€uller
cells, and neurons, while the complement inhibitor CFH and
CFI proteins were present in all cell types except the vascular
cell population. Alternative pathway protease CFDwas identified
in the M€uller cell and RPE fraction, while C6 was only found in
neurons and C7 was detected in M€uller cells and neurons. We
could not detect C4, C5, and C9 proteins in any of the retinal
cell populations (Figure 4E). For C8, no specific antibody was
commercially available. There was an overlap in the complement
transcript levels determined by quantitative real-time PCR and
that of the complement proteins detected in various cell popula-
tions. For example, the strong c1s mRNA expression found in
M€uller cells matched the robust C1s protein levels, and cfd
mRNA expression corresponded with CFD protein detection in
RPE. Interestingly, neurons expressed 40% of the total cfp
mRNA, whereas CFP protein levels were highest in microglia
(Figure 4E). This may imply a spatial separation of complement
component transcription and complement component accumu-
lation at the protein level within the retina.
Age-Dependent Changes in the Complement
Expression of Different Retinal Cell Populations
We further investigated age-dependent changes in expression
levels of known disease associated complement transcripts via
quantitative real-time PCR among the different retinal cell popu-
lations in mice from 8 to 24 weeks of age. C1s, cfb, cfp, and cfi
transcripts increased with age among all cell populations (Fig-
ure 5A). Upregulated c1s expression in RPE cells lead to
doubling of the total retinal c1s mRNA between 8 and 24 weeks
(Figure 5A). Transcripts of the alternative pathway activator cfb,
primarily produced by M€uller cells and RPE, increased at 16 and
24weeks of age. The largest increase in cfb transcript levels (2.6-
fold) was found in the microglial population between 8 and
24 weeks (Figure 5A). The highest proportional contribution of
cfp retinal transcripts came from neurons (55%) at 8 weeks of
age, and this contribution further increased to 73% at 16/
24 weeks of age (Figure 5A). In contrast, c3 expression remained
relatively stable (Figure 4E), except for the vascular cell popula-
tion, where the c3 levels dropped by 50% between 8- and 24-
week-old mice (Figure 5A).
CFH is themain negative regulator of the complement system.
We found that cfh expression decreased by 50% in all cell pop-
ulations in 24-week-old mice compared to 8-week-old mice. In
24-week-old mice, RPE cells produced the majority of the retinal
cfh (Figure 5A), although the majority of the cfi transcripts (which
act together with CFH) were produced by neurons, specifically
rod bipolar cells (Figures 1C and 5A). Together with its functional
counterpart, cfp, the expression of cfi also increased in neurons
of 24-week-old mice compared to the 8- and 16-week-old mice
(Figure 5A).
These divergent changes in the local complement expression
in the retina of aging mice were not accompanied by any detect-
able retinal cell loss (Figures 5B–5D) but were accompanied byCell Reports 29, 2835–2848, November 26, 2019 2841
Figure 6. Comparison of Complement
Component Expression between Retinal
Cell Types of Aging Mice
(A) Expression of complement components was
determined by quantitative real-time PCR. Dia-
grams represent the relative amount of transcripts
per cell (normalized to the idh3b housekeeper
expression) of the different complement compo-
nents in the respective cell type enriched from
mice at the indicated age. Note the high expres-
sion level of inhibitory complement factors in RPE/
choroid samples as well as in microglial and
vascular cells, while complement-activating genes
appear to dominate in M€uller cells and neurons.
Data were collected from 4‒6 wild-type albino
mice (numbers are given in Table S4).
(B) Complement expression analysis by quantita-
tive real-time PCR was performed on enriched
retinal cell types from 8-, 16-, and 24-week-old
mice. Bars represent mean values ± SEM of cells
purified from 4‒6 animals. Mann-WhitneyU testing
was performed on all data. A circle indicates a
significant difference compared to the expression
level at 8 weeks of age; whereas a diamond in-
dicates a significant difference compared to the
expression level at 16 weeks of age. />p < 0.05;
 />>p < 0.01.
See also Figure S2 and Table S7.increased microglia numbers (Figure 5E) and enhanced micro-
glial activation, as suggested by a decreased occupied area of
microglial processes (Figure 5E).A Characteristic Proportion of Activating and Inhibiting
Complement Transcripts in Distinct Retinal Cell Types
Having noted a cell-type-specific complement expression in our
data, we sought to understand the balance of complement acti-
vator and inhibitor expression in the different cell types by
normalizing complement expression levels to the housekeeping
gene to allow a comparison between cell populations indepen-
dent of cell counts (Figure 6). Strikingly, we discovered that
certain cell types like RPE and microglia mainly express inhibi-
tory complement components (cfh and cfi), whereas other cell
populations, such as neurons and M€uller cells, mostly express
complement activators (c1s, c3, cfb, and cfp) (Figure 6A). Inter-
estingly, neurons expressedmore cfi than cfh than the remaining
cell types (Figure 6A).
Finally, we checked for age-dependent changes in the expres-
sion of the respective complement components—now, in
contrast to results presented in Figure 5A, independent of puta-
tive changes in cell numbers. We could confirm a significant up-
regulation of complement activators such as c1s, c3, cfb, and
cfp with increasing age (Figure 6B). Most of these changes
were detected in RPE cells but at later stages (e.g., 24-week-
old mice) also in microglia, vascular, andM€uller cells. Expression
changes of complement inhibitors were not consistent across
cell types. While cfh was significantly downregulated in M€uller
glia in mice at 16 weeks of age, it was upregulated in RPE. More-2842 Cell Reports 29, 2835–2848, November 26, 2019over, cfi was significantly downregulated in microglia but upre-
gulated in M€uller glia, retinal neurons, and RPE.
The spatial distribution of complement activators and regula-
tors signifies a unique complement signature for each retinal
cell type that was dynamically changing, even though relatively
short intervals of aging were investigated.
Acute Ischemic Retinal Injury Triggers Robust Cell-
Type-Specific Complement Expression
Retinal tissue injury is a commonmanifestation of retinal disease.
To evaluate how tissue injury might change cell-type-specific
complement expression, we used a retinal ischemia/reperfusion
(I/R) injury model to induce acute retinal degeneration (Wagner
et al., 2017). We found a significant increase in the expression
of complement activators 24 h post-ischemia in the different iso-
lated cell populations (Figure 7). Consistent with our previous re-
sults, cfi appeared to be the main complement inhibitor in
neurons, whereas cfh was the major complement inhibitor ex-
pressed in the remaining cell populations. Compared to aging
retina (Figures 5 and 6), the upregulation of c1s, c3, cfb, and
cfi transcript expression of was more pronounced in post-
ischemic retina at the mRNA level (Figures 7A–7C). Interestingly,
this response in c1s, c3, and cfb expression was provoked by
changes in the RPE. Moreover, cfh and cfi showed again amutu-
ally opposite pattern of expression changes whereby cfhmRNA
decreased and cfi increased in I/R retinae (Figure 7C). Detection
of C3 (Figure 7D) and C1s (Figure 7E) at protein level via immu-
nolabeling 3 days after the ischemic tissue injury was performed
to enable detection of newly formed protein. C1s puncta were
evenly distributed over all retinal layers, with a slight enrichment
Figure 7. Transient Ischemic Stress Results in Cell-Type-Specific Upregulation of Transcripts from Activating Complement Components
and Downregulation of cfh
(A) The relative amount of complement transcripts per retinal cell type indicated that complement-activating transcripts are more abundant in pigmented mice
than in albino mice in which transcripts of complement inhibitors dominate at the same age. Note the strong relative upregulation and the resulting shift toward
transcripts from complement activators 24 h after transient ischemic retinal stress in all retinal cell types of C57BL/6 mice (numbers are given in Table S5).
(B) Major changes of local complement expression (normalized to the housekeeper) were detected by quantitative real-time PCR 24 h after transient ischemia.
The most pronounced upregulation of complement activators was found in M€uller cells (c3 and cfb), microglia (c3, cfb, and cfp) and RPE (c1s and c3). Cfh was
downregulated in M€uller cells, while cfi was upregulated in all investigated cell types. Significantly different expression as compared to that cells from healthy
control eyes is indicated (*p < 0.05, **p < 0.01, Mann-Whitney U test).
(C) Complement transcript contribution of the different retinal cell populations (no normalization to the housekeeper and no adjustment of RNA input) indicated a
pro-inflammatory milieu in the post-ischemic retina. M€uller cells, microglia, and RPE cells mainly contributed to the changed complement homeostasis in post-
ischemic retinae.
(legend continued on next page)
Cell Reports 29, 2835–2848, November 26, 2019 2843
in the GCL and RPE (Figure 7D). Similarly, C3 labeling was
observed in all retinal layers, and a moderate rise in labeling in-
tensity could be observed 3 days after the ischemic tissue injury,
especially in the outer retina affecting photoreceptors and RPE
(Figure 7E). Complement components are typically secreted by
the producing cells. In line with this fact, we did not find a perfect
cell-type-specific match of protein distribution compared to the
transcript signatures described above. It has to be considered
that ischemic damage may lead to transient breakdown of the
blood retinal barrier and that the complement components de-
tected via this approach could also be derived from the systemic
complement system, at least in post-ischemic tissue.
DISCUSSION
Since the retina is an immune-privileged tissue, understanding
its local complement system is critical to our understanding of
retinal inflammation. To identify the retinal cell types expressing
complement, we isolated and sequenced 92,000 cells from
healthy mouse retinae. scRNA-seq was validated by RNA-FISH
analysis for selected genes and 12 complement components
by assays of RNA and protein in enriched cell populations of
M€uller cells, microglia, vascular cells, retinal neurons, and RPE.
Collectively, our results show that complement components
are locally expressed by different retinal cell populations, chal-
lenging the conventional belief that the complement source in
the retina is confined to resident immune cells. We detected
complement transcripts and proteins that were produced at
higher levels in the neuroretina than in RPE that would be suffi-
cient to activate the classical and/or alternative complement
pathway. In consequence, cleavage of C3 into its anaphylatoxin
C3a and opsonin C3b could be performed independently of
blood-derived complement components (Figure 4F). Comple-
ment transcripts of the components that are key to MAC assem-
bly were primarily detected in RPE and rarely found as proteins in
the neuroretina. The RPE forms the outer retina-blood barrier,
which is able to secrete substrates not only toward the subretinal
space (apical) but also toward the choroidal side (basal). Consid-
ering its complement expression profile and the largely under-
studied idea of a context-specific apical or basal secretion
pattern of complement by RPE sitting at the blood-retinal inter-
face, it is tempting to speculate that by doing so, the RPE could
actively shape the complement homeostasis of the retina, which
needs to be addressed in future studies.
Given the cell-specific ratios of activating and inhibiting com-
plement component expression levels, each cell type appears to
have a specific role in maintaining retinal complement homeo-
stasis. Moreover, cell populations present in the retina at rela-
tively low numbers, such as microglia and M€uller cells (Jeon
et al., 1998), seem to have a major impact on retinal complement
expression levels. We found that these cells contribute substan-
tially to the total retinal transcriptome. This suggests that quan-(D) Representative immunostaining of complement component C1S and C3 in the
co-labeled for the M€uller cell marker glutamine synthetase (GLUL), and nuclei we
(E) Representative micrographs of retinal sections incubated with the combinatio
GCL, ganglion cell layer; IPL, inner plexiform layer; INL, inner nuclear layer; OPL, o
Scale bars, 20 mm. In (A) and (B), data were collected from 3 ‒ 5 animals. See al
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about the contribution of cellular activity to the global expression
profile of the retina. Nonetheless, it has been shown that tran-
scription is tightly regulated according to cell size, and cells
with larger cell bodies, such as M€uller cells, can provide more
mRNA than the more abundant cells with a smaller volume
(e.g., neurons and RPE) (Marguerat and Ba¨hler, 2012; Kempe
et al., 2015).
The complement system helps maintain normal ocular func-
tions (Sohn et al., 2003, 2000), and its dysregulation significantly
influences retinal disease (Sudharsan et al., 2017; Radu et al.,
2011; Weber et al., 2014; Yang et al., 2016; Scheetz et al.,
2013). Although earlier studies have found low background
expression of complement in retinal microglia (Luo et al., 2011;
Scha¨fer et al., 2017; Anderson et al., 2010; Rutar et al., 2012)
and RPE/choroid (Scha¨fer et al., 2017; Luo et al., 2011, 2013),
our results unequivocally show that other cell types are capable
of local complement production. We did observe expression dif-
ferences between the scRNA-seq and the MACS-enriched cell
populations that can be explained by the lower sensitivity to
detect gene expression compared to quantitative real-time
PCR. For instance, compared to the single-cell analysis, quanti-
tative real-time PCR allowed us to more readily detect the
expression of c1s and c3 in M€uller cells, cfp in microglia and
vascular cells, cfb in all major retinal cell types, and cfd, c5‒c9
mainly in RPE cells. Still, both approaches converged in their
assessment of cell-type-specific expression for most comple-
ment components. Our results also add to previous work on
retinal complement in humans (Tian et al., 2015; Li et al., 2014;
Anderson et al., 2010), mice (Scha¨fer et al., 2017; Luo et al.,
2011), and rats (Rutar et al., 2012) by also detecting protein
expression for nine complement components that reflect their
RNA expression.
The regulation of complement expression in whole-cell popula-
tions from the aging retina largely matched the changeswe calcu-
lated for the normalized cellular expression rates in the distinct cell
types. This implies that expression changes were driven by
changes at the transcriptional level, not by changes in cell
numbers, in accordance with the data from our morphometric an-
alyses performed on aging BALB/cmice. Interestingly, the relative
expression of all tested complement components increased in the
whole-RPE-cell population with increasing age, except for cfh,
whose expression decreased. We speculate that increased sin-
gle-cell cfh expression alone is unable to counterbalance the
overall age-associated RPE dysfunction and/or degeneration
(as also indicated by a reduced rpe65 expression). Accordingly,
RPE-dependent cfh transcripts decrease at 24 weeks, the puta-
tive contribution of cfh in regulating the alternative complement
pathway in the retinal microenvironment could be diminished,
and the intraretinal milieu could be misbalanced.
We also discovered that healthy neurons produce the comple-
ment regulators cfp and cfi. The relevance of these complementhealthy and post-ischemic pigmented retina 3 days after injury. Sections were
re visualized by DAPI co-labeling.
n of secondary antibodies and DAPI only.
uter plexiform layer; ONL, outer nuclear layer; RPE, retinal pigment epithelium.
so Figure S2 and Table S7.
components has already been shown for AMD (Fritsche et al.,
2016; Weber et al., 2014; Micklisch et al., 2017). In murine
models of retinal degeneration, cfi expression increases after
polyethylene-glycol-induced insult, whereas cfp expression de-
creases in the light-damaged retina (Scha¨fer et al., 2017; Lyzo-
gubov et al., 2014). Our single cell analysis demonstrated that
cfi mRNA localizes specifically to rod bipolar cells and protein
detection to neurons and M€uller cells in mice. CFI inactivates
the complement system, and the resulting cleavage products
modulate the activity of phagocytes. Rods primarily govern
scotopic vision, and mice have a rod-dominated retina similar
to humans (except for the fovea centralis). This rod-bipolar-
cell-specific cfi transcription in themouse retina further suggests
that the retinal complement system is influenced by functional
and anatomical characteristics of the retina.
Age-related anatomical alterations in the retina have been
demonstrated in histological analyses (Grossniklaus et al.,
2013). Consistent with previous results (Damani et al., 2011;
Friedman and Ts’o, 1968), we found increased microglial and
decreased RPEmarker gene expression with aging. In our study,
the expression of complement transcripts c1s, cfb, cfp, and cfi
increased while that of cfh decreased in retinal cells between 8
and 24 weeks of age. This indicates a role for complement in
retinal adaptation during maturation and with processes of aging
(Mukai et al., 2018). Although age-dependent upregulation of
complement transcripts, including that of c1q, c3, c4, and cfb,
in the retina has been described (Chen et al., 2010), our findings
add a role for microglia in the expression of c3 and cfb. Our re-
sults also show that M€uller cells and neurons provide a substan-
tial proportion of retinal complement transcripts and, thus, their
impact on retinal complement homeostasis has likely been
underestimated by past studies. Cell culture studies have
suggested that M€uller glia can produce C1q (Astafurov et al.,
2014) and that complement activation products can regulate
M€uller cell activity via C5a-receptor and influence retinal disease
(Cheng et al., 2013a). Our results show a direct involvement of
M€uller cells in the transcript expression of the retinal comple-
ment components, and it is likely that in the retina, similar to
the brain, neurons and glia cells orchestrate complement-medi-
ated maturation of nervous tissue via synaptic pruning, progen-
itor proliferation, and neuronal migration (Tenner et al., 2018).
Aging and Alzheimer disease brains increase expression of
c1q, c3, and c4 (Walker and McGeer, 1992; Cribbs et al.,
2012), which might point to a general mechanism of local com-
plement function in the overall aging of the CNS.
Ischemia and subsequent reperfusion (e.g., upon treatment
with anti-VEGF therapy) are associated with diabetic retinopathy
(Silva et al., 2015; Traveset et al., 2016; Levin et al., 2017), and
polymorphisms in CFB and CFH (Wang et al., 2013) have been
implicated in modifying disease progression. We identified
M€uller cells as a major cell type involved in this process (by
downregulating cfh transcripts and upregulating cfb) in the anal-
ysis of post-ischemic mouse retina. Gene profiling studies of
whole mouse retinas also suggest an important role of the com-
plement pathway in I/R-associated damage (Andreeva et al.,
2014). Retinal c1q, c1s, c1r, c2, c3, c4a, and cfh expression
has been reported after transient ischemia in mice (Kuehn
et al., 2008; Kim et al., 2013; Andreeva et al., 2014). However,it remains undetermined how individual retinal cell types modu-
late complement activity after retinal I/R injury. Here, we show
that mainly M€uller cells, microglia, and RPE increase c3 and
cfb expression following ischemia, while cfp is upregulated pri-
marily in microglia. The complement inhibitor cfi also showed
cell-type-specific enhanced mRNA levels in microglia, RPE,
and retinal neurons, whereas expression of the complement in-
hibitor cfh was significantly reduced in M€uller cells following
ischemia. These expression changes suggest augmentation of
local complement components following ischemia.
Genetic variation in several complement genes, such as CFH
andCFI, are associatedwith AMD, glaucoma, and central serous
retinopathy (Fritsche et al., 2016; Weber et al., 2014; Grassmann
et al., 2016). CFI, along with cofactor CFH, regulates comple-
ment activity by degrading complement components C3b and
C4b (Davis et al., 1984), thereby facilitating the cleavage of
C3b into inactive fragments (Sim et al., 1993). We discovered a
spatially distinct transcription pattern of cfi and its cofactor,
cfh. cfiwasmainly detected in retinal neurons (specifically rod bi-
polar cells), while cfhwas detected primarily in vascular and RPE
cells. Further, we found opposing transcriptional regulation of cfi
and cfh during aging and ischemia. These findings hint at a CFH-
independent function of CFI in the retina, perhaps in conjunction
with other cofactors such as CR1 or CD46 (Sim et al., 1993). To
date, there are no known AMD-associated polymorphisms in the
cd46 or cr1 genes, but cd46 knockout induces retinal degener-
ation (Lyzogubov et al., 2016), highlighting its relevant role in
retinal physiology.
Given the cell-type-specific expression profile of complement
genes in the retina, we propose that a balanced local comple-
ment expression is linked to normal retinal integrity. Moreover,
our data show that changes in local, cell-type-specific comple-
ment expression during aging and acute stress can be induced
by cell stress and retinal degeneration and, thus, could in the
end also contribute to disease progression. For example, a reac-
tion common to I/R damage and aging appears to be the
decrease of intraretinal expression of the complement inhibitor
cfh. This working hypothesis of course needs further validation
at the functional level by future studies.
Taken together, our cell-type-specific analyses provide an
alternative perspective on how expression of complement
genes, such as those identified by a genome-wide association
study (GWAS) for AMD and diabetic retinopathy, in various
retinal cell types might be involved in the disease mechanisms
in question. The tightly orchestrated reaction of all retinal cell
types to distinct conditions of tissue stress suggests that cell-
type-specific responses must be considered for successful
development of therapeutic strategies targeting retinal comple-
ment activity in the future.
Finally, it needs to be pointed out that the analysis of comple-
ment activation and its putative role during retinal development,
aging, and retinal degeneration was beyond the scope of the
present study that was primarily set up to generate a detailed
retinal complement expression atlas. However, complement
function in the aforementioned processes (irrespective of its
source) has been partially addressed and demonstrated by other
research groups in the field (Sohn et al., 2003, 2000; Radu et al.,
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2014; Yang et al., 2016). We would like to point out that those
local complement transcripts we were able to detect in distinct
retinal cell types are sufficient to activate the classical and alter-
native complement pathways. Given the rather low expression of
components of the terminal canonical complement pathway in
cells from the neuroretina, it remains debatable whether it can
be intraretinally active without input from the RPE that did pro-
duce moderate levels of respective transcripts and/or the sys-
temic complement system. However, we also would like to
stress the point that those complement components we demon-
strated to be locally expressed are likely to have non-canonical
functions in the retina (e.g., C3 in synapse pruning or CFH in
phagocytosis or apoptosis) (Martin et al., 2016; Hawksworth
et al., 2017). There is growing evidence for intracellular functions
of early complement components, which could have an impact
on normal cellular physiology (Liszewski et al., 2017). To follow
up this intriguing line of thinking, future studies are needed to
identify these intracellular functions in addition to their cell secre-
tion and functional interactions.STAR+METHODS
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Single cell RNA-Seq and RNA-FISHwas performed on wild-type (C57BL/6J) malemice (10 weeks old) purchased from Jackson Lab-
oratory (Bar Harbor, ME, USA). All experimental procedures were approved by the University of Pennsylvania Animal Care and Use
Committee.Micewere sacrificedwith cervical dislocation under anesthesia. Experiments for immunomagnetic separationwere done
in accordance with the European Community Council Directive 2010/63/EU and the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research and were approved by the local Bavarian authorities (55.2 DMS-2532-2-182, Germany). All mice
were housed in a 12 hour light/ dark cycle with 400 lux. Experiments on complement expression in aging mice were conducted
with 8, 16 and 24 week old male and female on BALB/cmice. Retinal ischemia was induced in one eye of 8 week old male and female
C57BL/6J mice. The untreated contralateral eye served as internal control and, accordingly, an additional control group was not
needed thereby sticking to the rules of the three R’s by keeping reducing the number of animals used in respective experiments.
METHOD DETAILS
Retinal ischemia/ reperfusion injury
The protocols for induction of transient retinal ischemia were approved by the local Bavarian authorities (55.2 DMS-2532-2-182,
Germany). Ischemia was induced in one eye of 8 week old male and female C57BL/6J mice using the high intraocular pressure
(HIOP) method (Pannicke et al., 2014;Wagner et al., 2016). The other eye remained untreated and served as an internal control. Anes-
thesia was induced with ketamine (100 mg/kg body weight, intraperitoneal (ip); Ratiopharm, Ulm, Germany), xylazine (5 mg/kg, ip;
Bayer Vital, Leverkusen, Germany), and atropine sulfate (100 mg/kg, ip; Braun, Melsungen, Germany). The anterior chamber of
the test eye was cannulated from the pars plana with a 30-gauge infusion needle, connected to a saline bottle. The intraocular pres-
sure was increased to 160 mmHg for 90 minutes by elevating the bottle. After removing the needle, the animals survived for 24 hours
and subsequently, they were sacrificed with carbon dioxide for tissue analyses.
Single Cell RNA Analysis of mouse retina
Mouse eyeballs were quickly removed and placed in cold phosphate buffered saline (PBS). The mouse retina was carefully removed
under dissecting scope and tissue was dissociated immediately using the papain dissociation system (Worthington, Lakewood, NJ,
USA) following the manufacturer’s instructions. Briefly, the mouse retina was incubated at 37C for 30 minutes in Eagle’s Balanced
Salt Solution (EBSS) with DNase followed by tissue trituration with a 10 mL pipette. Cell pellet was collected after centrifugation at
3003 g for 5 minutes and then resuspended in DNase albumin-inhibitor solution. The cell suspension was carefully layered on top of
the albumin-inhibitor solution, then centrifuged at 70 3 g for 6 minutes. The cell pellet was washed and resuspended in 1:1 DMEM/
F12 + 10% FBS. All centrifugation steps were performed at room temperature. The final cell suspension was filtered with 40 mm cell
strainer (Falcon, Corning, NY, USA) to remove large debris. To assess cell viability, cells were stained with 0.4% trypan blue (Medi-
atech, Inc., Manassas, VA, USA) and counted using a hemocytometer. Viable cells (greater than 80%) were submitted to the Center
for Applied Genomics at the Children’s Hospital of Philadelphia (CHOP) for cell separation and lysis on the 10X Chromium Genomics
instrument and sequencing on the Illumina Hi-Seq instrument.
All analyses were carried out in the statistical softwareR v 3.5.1. The R package Seurat was used for data analysis, dataset merging
and cell clustering analysis. For clustering, we used 2000 or more genes that had detectable expression with high variability in the
92,000 mouse retinal cells. Six genetically identical C57BL/6J mice were sequenced, our data were consistent across different
batches (Figure S1). We filtered out low-quality cells in which < 90% of the reads did not map to the genome using the Cell Ranger
pipeline from 10x genomics, and ultimately obtained 92,343 cells used in our subsequent analyses. Given the consistent number of
genes (nGene), UMIs (nUMI), and the percentage of mitochondrial genes (percent.mito) detected in each batch, we merged the
sequencing runs and used 30 principal components as an input to t-distributed stochastic neighbor embedding (t-SNE) method
for dimension reduction and data visualization. We found 25 cell clusters within the retina using an unsupervised analysis that dide2 Cell Reports 29, 2835–2848.e1–e4, November 26, 2019
not rely on known markers of retinal cells. Marker genes were identified for all clusters with the functionmarkers.all in the R package
Seurat; all marker genes with power less than 0.4 were discarded. Moreover, only cells with mitochondrial gene percentages < 50%,
and those with unique gene counts between 200 and 3,500 were used, leaving us with 91,798 retinal cells. After filtering, we sought to
consolidate the 25 clusters into a total of 11 (for N = 91,798 cells), each of which represents amajor, functionally important cell class in
the retina. For this, we used the known, established marker genes for common retinal cell types summarized in Table S1. Although
previous studies of scRNA-seq on the mouse retina have identified more than 30 different cell types, this difference is largely ex-
plained by their subdivision of bipolar cells (BCs) into numerous sub-categories. We decided to classify cell types based on general
categories because we wanted to study complement expression in retinal cells more broadly. Using this approach, the cell type pro-
portions in the retina proper are comparable between our study and past studies. Based on mean complement gene expression, we
categorized positive expression for a gene within a cell type only if eitherR 5% of cells or at least 50 cells within that class had non-
zero expression for that gene.
RNA-FISH
Mouse protocol was approved by the University of Pennsylvania IACUC committee. A 10 week old C57BL/6J male was euthanized
with 5 mg pentobarbital sodium. The eye was dissected free from the orbit, washed in PBS, embedded in OCT (Tissue Tek, Sakura
Finetek USA, Torrance, CA, USA) and immediately snap-frozen in liquid nitrogen. The frozen tissue was sliced at 10 mmon a cryostat
and stored at 80C on glass slides.
Tissue fixation and RNA in situ hybridization (RNA-FISH) was carried out using Stellaris RNA FISH (LGC Biosearch Technologies,
Petaluma, CA, USA) following the manufacturer’s instructions. Briefly, the tissue section was fixed in 3.7% formaldehyde in 1X PBS
for 10minutes at room temperature. After washing twicewith 1X PBS, the tissue sectionwas permeabilized in 70%ethanol for at least
1 hour at room temperature. Oligo probes were designed against mRNA coding sequence for each gene using the Stellaris Custom
probe sets and labeled with Quasar 570 dye or Quasar 670 dye. For a positive control, mouse GAPDH probe (Stellaris ShipReady
probe sets) was purchased. To secure tissues on the slide during hybridization, the HybriWell sealing system (Grace Bio-Labs,
Bend, OR, USA) was used. Each tissue section was incubated in hybridization buffer containing probe (final concertation was be-
tween 62.5 nM to 250 nM) overnight at 37C and then washed in washing buffer A for 30 minutes at 37C. Cell nuclei were stained
with 40,6-diamidino-2-phenylindole (DAPI, 0.1 mg/ml) followed by washing in Buffer B. All buffers were purchased from LGC Bio-
research Technologies. Finally, mounting medium (ProLong Gold antifade reagent, Invitrogen, Life Technologies, Eugene, OR,
USA) was added and a coverglass was mounted on the slide. Confocal microscopy to image the RNA-FISH samples was performed
at the Bioimaging Core Facility of the Biomedical Center of the LMUMunich. RNA FISH images were obtained with an inverted Leica
SP8X WLL microscope with a 63x/1.3 Glyc objective. We sequentially recorded Quasar 670 (excitation 647 nm; emission 670 nm -
760 nm) and Quasar 570 (excitation 556 nm; emission 566 nm - 630 nm) with hybrid photo detectors (HyDs) and DAPI (excitation
405 nm; emission 415 nm - 450 nm) with a conventional photomultiplier tube. The same illumination and acquisition settings were
used for all sections. Brightness and contrast of the images were adjusted with the open source software FIJI (ImageJ; National In-
stitutes of Health, Bethesda, MD, USA).
MACS enrichment of retinal cell types
Retinal cell types were enriched as described previously using magnetic-activated cell sorting (MACS) (Grosche et al., 2016). Briefly,
retinaewere treatedwith papain (0.2mg/ml; RocheMolecular Biochemicals) for 30minutes at 37C in the dark in Ca2+- andMg2+-free
extracellular solution (140 mM NaCl, 3 mM KCl, 10 mM HEPES, 11 mM glucose, pH 7.4). After several washes and 4 minutes of in-
cubation with DNase I (200 U/ml), retinae were triturated in extracellular solution (now with 1 mM MgCl2 and 2 mM CaCl2). To purify
microglial and vascular cells, the retinal cell suspension was subsequently incubated with CD11b- and CD31 microbeads according
to the manufacturer’s protocol (Miltenyi Biotec, Bergisch Gladbach, Germany). The respective binding cells were depleted from the
retinal suspension using LS-columns, prior toM€uller cell enrichment. To purify M€uller glia, the cell suspension was incubated in extra-
cellular solution containing biotinylated anti-CD29 (0.1 mg/ml, Miltenyi Biotec) for 15 minutes at 4C. Cells were washed in an
extracellular solution, spun down, resuspended in the presence of anti-biotin MicroBeads (1:5; Miltenyi Biotec,) and incubated for
10 minutes at 4C. After washing, CD29+ M€uller cells were separated using large cell (LS) columns according to the manufacturer’s
instructions (Miltenyi Biotec). Cells in the flow through of the last sorting step- depleted of microglia, vascular cells and M€uller glia-
were considered as the neuronal population. RPE was collected by scratching the eye cup after the retina had been removed and
thus, scratch samples also contained cells from the underlying choroid. Samples were digested, and in subsequent steps, macro-
phages were depleted using anti-CD11b-microbeads and vascular cells using CD31-microbeads (Miltenyi Biotec).
qRT-PCR
Total RNA was isolated from the enriched cell populations using the PureLink RNA Micro Scale Kit (Thermo Fisher Scientific,
Schwerte, Germany). A DNase digestion step was included to remove genomic DNA (Roche). We performed RNA integrity validation
and quantification using the Agilent RNA 6000 Pico chip analysis according to the manufactures instructions (Agilent Technologies,
Waldbronn, Germany). First-strand cDNAs from the total RNA purified from each cell population were synthesized using the
RevertAid H Minus First-Strand cDNA Synthesis Kit (Fermentas by Thermo Fisher Scientific, Schwerte, Germany). We designed
primers using the Universal ProbeLibrary Assay Design Center (Roche, Table S6) and measured transcript levels of candidate genesCell Reports 29, 2835–2848.e1–e4, November 26, 2019 e3
by qRT-PCR using the TaqMan hPSC Scorecard Panel (384 well, ViiA7, Life Technologies, Darmstadt, Germany) according to the
company’s guidelines.
LC-MS/MS mass spectrometry analysis
LC-MS/MS analysis was performed as described previously (Frik et al., 2018; Lepper et al., 2018) on a Q-Exactive HF mass spec-
trometer (Thermo Fisher Scientific Inc., Waltham, MA, U.S.A.) coupled to an Ultimate 3000 RSLC nano-HPLC (Dionex, Sunnyvale,
CA). Briefly, 0.5 mg sample was automatically loaded onto a nano trap column (300 mm inner diameter3 5 mm, packed with Acclaim
PepMap100 C18. 5 mm, 100 A˚; LC Packings, Sunnyvale, CA) before separation by reversed phase chromatography (HSS-T3M-class
column, 25 cm,Waters) in an 80minutes non-linear gradient from 3 to 40%acetonitrile (ACN) in 0.1% formic acid (FA) at a flow rate of
250 nl/min. Eluted peptideswere analyzed by theQ-Exactive HFmass spectrometer equippedwith a nano-flex ionization source. Full
scan MS spectra (from m/z 300 to 1500) and MS/MS fragment spectra were acquired in the Orbitrap with a resolution of 60,000 or
15000 respectively, with maximum injection times of 50 ms each. Up to ten most intense ions were selected for HCD fragmentation
depending on signal intensity (TOP10 method). Target peptides already selected for MS/MS were dynamically excluded for 30 s.
Spectra were analyzed using the Progenesis QI software for proteomics (Version 3.0, Nonlinear Dynamics, Waters, Newcastle
upon Tyne, UK) for label-free quantification, as previously described (Grosche et al., 2016). All features were exported as a Mascot
generic file (mgf) and used for peptide identification with Mascot (version 2.4) in the UniProtKB/Swiss-Prot taxonomy mouse data-
base (Release 2017.02, 16871 sequences). Search parameters used were: 10 ppm peptide mass tolerance, 20 mmu fragment mass
tolerance, one missed cleavage allowed, carbamidomethylation set as fixed modification, and methionine oxidation, asparagine or
glutamine deamidation were allowed as variable modifications. A Mascot-integrated decoy database search calculated an average
false discovery rate (FDR) of < 1%.
Western blot
Cell pellets of enriched cell populations from pooled pair of mouse eyes were dissolved in reducing Laemmli sample buffer, dena-
tured and sonicated. Neuronal protein extraction reagent (Thermo Fisher Scientific, Braunschweig, Germany) was added to the
neuron populations. Samples were separated on a 12%SDS-PAGE. The immunoblot was performed as previously described (Scha¨-
fer et al., 2017). Detection was performed with primary and secondary antibodies diluted in blocking solution (Table S7). Blots were
developed with WesternSure PREMIUM Chemiluminescent Substrate (LI-COR, Bad Homburg, Germany). To validate specificity of
the antibodies, all of them were tested on mouse serum as positive control (Figure S3).
Immunofluorescent labeling of retina and RPE
To quantify cell nuclei and perform stainings for C1s, C3 and glutamine synthetase (GLUL) in retinal sections of 4%paraformaldehyde
(PFA)-fixated and paraffin-embedded murine eyes, the sections were deparaffinised and incubated with Hoechst33342/DAPI
(1:1000; #H1399, Thermo Fisher Scientific, Braunschweig, Germany) or detection antibodies as previously described (Scha¨fer
et al., 2017) (Table S7). Images were acquired using confocal microscopy (VisiScope, Visitron Systems, Puchheim, Germany).
Retinal microglia quantification was performed in the retinal flat mounts. Anterior segments of mouse eyes were removed, and the
retina carefully separated. Flat mounts were fixated in 4% PFA (retina 1 h room temperature), permeabilized (1% Triton X-100) and
blocked (1% BSA, 5% goat serum, 0.1 M NaPO4, pH 7). Retinal flat mounts were stained with anti-Iba1 antibody (3% Triton X-100,
1% DMSO, 5% normal goat serum, overnight at 4C) and secondary antibody (1% BSA in PBS, overnight at 4C) (Table S7). Retinal
flat mounts were embedded with photoreceptors facing down, and the GCL facing up. Images were taken with a confocal micro-
scope (VisiScope, Visitron Systems).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using Prism (Graphpad Software, San Diego, CA, USA). Inmost of the experiments in the present
study results from 4 biological replicates were collected to keep to the rules of the three Rs for the sake of animal welfare. Since this
low number of input values does not allow an appropriate estimation about a normal Gaussian distribution, significance levels were
determined by the non-parametric Mann-Whitney U test unless stated otherwise. All data are expressed as mean ± standard error
(SEM) unless stated otherwise. Detailed information about specific n-values, implemented statistical tests and coding of significance
levels are provided in the respective figure legends.
DATA AND CODE AVAILABILITY
The accesssion number for the single cell RNA-Seq data reported in this paper is GSE116426 (Gene Expression Omnibus (GEO)).
Other data supporting the findings of this study are available from the corresponding author upon request.e4 Cell Reports 29, 2835–2848.e1–e4, November 26, 2019
